InvestWiser

Mentice AB

MNTCNasdaq StockholmHealthcareMarket value 477 m SEK
16.95SEK +2.7%
last day · Price as of 18 November 2026

The answer first

Does Mentice beat the market?

Yes, Mentice has beaten the market over the last year.

Mentice+27.4%Stockholm (OMXSGI)+17.6%
  • The ranking · Quality, value and trend combined

    Better than 25% of Nordic stocks

    • Quality4
    • Value23
    • Trend89

    No. 119 of 195 in healthcare

  • Expectations in the price

    Low expectations

    For the share to return about 9% a year from today's price, the cash Mentice keeps must grow about 2% a year for 10 years.

Max for seven days

Follow Mentice with Aurora

Aurora lets you know at the next report. No card.

Both with dividends. Figures as of 18 November 2026. General analysis, not personal advice.

Follow your thesis

Follow your thesis on Mentice

From today, at a price of 16.95 SEK. Write why you follow Mentice, and choose what Aurora should tell you about.

What should Aurora follow?

Free, no card. The mission is ready when your account is.

Aurora tells you that something happened. What you do is your choice.

Ask Aurora about Mentice

Your first answer is free, no account needed.

Do you own Mentice, or are you thinking about it?

See it next to the rest of your portfolio, or build your first one with Mentice and a few more. Free, no card.

Past year against the exchange and Super Stock
Mentice+27.4%Stockholm (OMXSGI)+17.6%Super Stock+44.6%
17 November 202518 November 2026
All start at 0 % a year ago, with dividends. Super Stock is our model portfolio: the 20 highest-ranked Nordic stocks on quality, value and trend.

In short

  • Mentice has risen 27.4% over the past year, including dividends.
  • Overall, Mentice ranks better than 25% of Nordic stocks on quality, value and trend.
  • The largest fall over the past three years was 86.3%. The price is 90.8% below its peak now.

What do analysts think of Mentice?

Quality, value and trend

Quality is about the company, value about the price you pay, and trend about the share price. Each pillar shows the numbers it is built on.

25

Quality, value and trend together. Better than 25% of Nordic stocks.

No. 119 of 195 in healthcare

Quality4
The company · Fundamentals: the accounts

Low Weaker accounts than most: low profitability, high debt or uneven results.

No. 192 of 196 in healthcareTypical in healthcare: 64Typical in the Nordics: 50

  • Debt to equityBorrowings divided by equity0.20
  • Asset turnoverSales divided by everything the company owns1.01
  • Return on equityProfit divided by equity−16.8%
  • Cash conversionOperating cash flow divided by profit–

The ranking is built on equity ratio, ROA and how steadily profit grows.

Value23
The price · Valuation: the multiples

Low High price: buyers pay a lot today, often because they expect growth.

No. 89 of 197 in healthcareTypical in healthcare: 20Typical in the Nordics: 50

  • P/BPrice divided by equity4.2
  • P/SPrice divided by sales1.5
  • P/EPrice divided by earningsnegative earnings
  • P/CFPrice divided by operating cash flow12.5

The ranking is built on P/E, P/B and P/S.

Trend89
The share price · Technical: the price trend

High Tailwind in the share price: it has risen more than most over the last year.

No. 27 of 198 in healthcareTypical in healthcare: 34Typical in the Nordics: 50

  • 3 months+26.5%
  • 6 months+10.4%
  • 9 months+36.1%
  • 12 months+27.4%

The ranking is built on 3, 6 and 12–1 months.

Return and risk

1 month
+7.3%
3 years, per year
−21.1%
5 years, per year
−31.5%
Year to date
+27.0%
Largest fall, 3 years
−86.3%
From a peak to the bottom
From the peak now
−90.8%
How far the price is from the peak
Volatility, 1 year
48.4%
How much the price swings over a year
Beta, 1 year
0.59
How much the price moves when the market moves

Return with dividends reinvested.

The funds that own Mentice

One fund we follow owns Mentice. The share is how much of the fund the stock makes up.

  • Sweden1

From the funds' latest known holdings.

About Mentice

Mentice AB is a company in healthcare, listed on Nasdaq Stockholm. The share trades in SEK. It has around 130 employees.

Mentice AB (publ), together with its subsidiaries, develops, sells, and markets solutions for training and decision support in the clinical area of interventional angiography in cardiology, neurology, vascular surgery, and radiology. It operates through the Mentice VIST, Physical Sim, and Ankyras segments. The company offers virtual simulation products, including VR simulator platforms; procedural learning models; peripheral vascular; patient simulator accessories and extensions for endovascular therapies; and Angiosuite integrations, such as the VIST virtual patient and Laerdal SimMan vascular medical simulator.

See the full analysis of Mentice.

The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.

Free forever · No card

Other healthcare stocks on Nasdaq Stockholm

Explore the stock market